Illumina Inc. sued rival DNA sequencing company BillionToOne Inc. for allegedly infringing three of its patents related to noninvasive prenatal testing methods.

Illumina, Inc. ILMN recently announced the release of Illumina Connected Multiomics, a cloud-based research software platform to analyze and visualize multiomic and multimodal biological data at scale ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (NASDAQ: ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” investor letter for the first quarter of 2025. A copy of the letter can be downloaded here. The first quarter of ...

Illumina Multiomics Summit India highlights integrated omics to drive precision healthcare & biomedical research: Our Bureau, Bengaluru Monday, May 11, 2026, 14:15 Hrs [IST] Illum ...

-- Company poised to accelerate revenue growth into high single digits over next three years, enabled by core genomics portfolio -- Innovations to enable development of transformative applications ...

Illumina, Inc. (NASDAQ:ILMN) announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson (NYSE:JNJ). This collaboration will be the first relating to the ...

Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2026 following the close of market on Thursday, April 30, 2026.

Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies.

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the ...